Are We All Global Now ? Local Versus Foreign Sources of Corporate Competence : The Case of The Japanese Pharmaceutical Industry  

Oleh:

L. G. Thomas III

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Strategic Management Journal vol. 25 no. 8 (Aug. 2004), page 865-886.
Topik: CORPORATE; capability; multinational firm; institutional environments; pharmaceutical industry; japan

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: SS30.16 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

This study the highly distinctive national contexts of the pharmaceutical industry to the evolution of innovative cpaabilities for japanese drug firms from 1975 to 1995. During these two decades, the japanese domestic environment for pharmaceuticals changed radically encouraging a "bubble" of trivial innovations. Experience by japanese firms in their domestic market predominantly determined their innovative capabilities, pushing these firms towards trivial innovation. Corporate experience in the socially "proximate" markets of southern europe serbed as a strategic complement for significant innovation by japaneses drug firms and thus as a partial counterweight to the home market. Unfortunately, corporate diversification was a strategic substitute for significant innovation and many japanese drug firms are significantly diversified. The resulting degradation of innovative capability for japanese drug firms has locked most of them into an increasingly unattractive home market.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali